Why is Philadelphia Pharmaceuticals Co. ?
1
Flat results in Dec 25
- OPERATING CASH FLOW(Y) Lowest at JOD 0.64 MM
- ROCE(HY) Lowest at 0%
- DIVIDEND PAYOUT RATIO(Y) Lowest at 154.19%
2
With ROE of 7.44%, it has a very attractive valuation with a 0.00 Price to Book Value
- Over the past year, while the stock has generated a return of 13.14%, its profits have risen by 19%
3
Underperformed the market in the last 1 year
- The stock has generated a return of 13.14% in the last 1 year, much lower than market (Jordan General Index) returns of 52.62%
How much should you hold?
- Overall Portfolio exposure to Philadelphia Pharmaceuticals Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Philadelphia Pharmaceuticals Co. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Philadelphia Pharmaceuticals Co.
13.14%
0.38
17.99%
Jordan General Index
52.62%
5.46
9.64%
Quality key factors
Factor
Value
Sales Growth (5y)
3.66%
EBIT Growth (5y)
16.11%
EBIT to Interest (avg)
1.03
Debt to EBITDA (avg)
0.32
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.59
Tax Ratio
21.07%
Dividend Payout Ratio
52.24%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.95%
ROE (avg)
4.90%
Valuation Key Factors 
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
-0.50
EV to EBITDA
-0.42
EV to Capital Employed
-0.06
EV to Sales
-0.08
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
7.44%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Bearish
No Trend
OBV
No Trend
Mildly Bearish
Technical Movement
5What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -15.01% (YoY
OPERATING PROFIT(Q)
Highest at JOD 0.62 MM
OPERATING PROFIT MARGIN(Q)
Highest at 26.76 %
PRE-TAX PROFIT(Q)
Highest at JOD 0.43 MM
NET PROFIT(Q)
Highest at JOD 0.34 MM
-9What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at JOD 0.64 MM
ROCE(HY)
Lowest at 0%
DIVIDEND PAYOUT RATIO(Y)
Lowest at 154.19%
CASH AND EQV(HY)
Lowest at JOD 1.6 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 0 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
EPS(Q)
Lowest at JOD 0
Here's what is working for Philadelphia Pharmaceuticals Co.
Operating Profit
Highest at JOD 0.62 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JOD MM)
Operating Profit Margin
Highest at 26.76 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JOD 0.43 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JOD MM)
Net Profit
Highest at JOD 0.34 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JOD MM)
Raw Material Cost
Fallen by -15.01% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Philadelphia Pharmaceuticals Co.
Operating Cash Flow
Lowest at JOD 0.64 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (JOD MM)
EPS
Lowest at JOD 0
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (JOD)
Cash and Eqv
Lowest at JOD 1.6 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Dividend Payout Ratio
Lowest at 154.19%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)






